SJW vs. Ginkgo vs. MDMA
ahhh good, thanks guys that's reassuring to hear

, but I ought to show you why I have this concern;
I've tried researching Ginkgo a bit, and came up with mixed results

I'll show you all what I've found, see if we can get to a definate conclusion!
"Extracts of Ginkgo biloba leaves produce reversible inhibition of rat brain monoamine (MAO). Both MAO-A and -B types were inhibited to a similar extent. The MAO inhibitory compound(s) were present in dried or fresh Ginkgo biloba leaves as well as in commercially available capsules of Ginkgo biloba and appear to be heat stable with relatively low molecular weight. MAO inhibition by Ginkgo biloba may be a mechanism underlying reported anti-stress and anxiolytic activities of this natural product. "
http://www.biopsychiatry.com/ginkgomaoi.html
"Studies have shown that the extract counteracts the gradual reduction in the number of serotonin receptor sites (which ecstacy does, causing down relegulation of receptor sites: eg: damaging them). Besides increasing the number of serotonin receptors sites, Ginkgo biloba extract may also enhance the effects of 5-HTP. Take it with 5-htp 4-5 hours before you drop, and take it after to help prevent and repair damage to serotonin receptors. But be careful and use it in moderation when taking it with X because ginkgo biloba can act as a mild MAOi. "
http://www.geocities.com/jdivx2002/info.rtf
"Ginkgo's use in depression may be due in part to its ability to increase cerebral blood flow.80 Ginkgo has been reported in laboratory studies to have monoamine oxidase inhibiting (MAOI) effects. MAOIs are a class of anti-depressant pharmaceuticals. Ginkgo has been found to inhibit both MAO-A and -B types to a similar extent.81 Ginkgo's MAOI ability may be one mechanism for its reported anti-stress and antidepressant uses. However, recent animal and human studies have reported that ginkgo administration does not produce significant changes in brain MAO-A or MAO-B, suggesting that mechanisms other than MAO inhibition need to be considered as mediating some of its antidepressant effects."
http://www.hsrmagazine.com/articles/2c1feat1.html
"The study was designed to determine whether Ginkgo Biloba extract could alter the number of serotonin receptors in aged (24 month old) and young (four-month-old) rats. At the beginning of the study the older rats had a 22 percent lower number of serotonin binding sites compared with the younger rats. The results of consistent treatment with Ginkgo biloba extract for twenty-one consecutive days demonstrated that there was no change in receptor binding in young rats, but in the aged rats there was a statistically
significant increase (by 33 percent) in the number of serotonin-binding sites. These results indicate that Ginkgo biloba extract may counteract at least some, if not all, of the age-dependent reductions of serotonin binding sites in the aging human brain as well. "
http://www.iherb.com/iherb/ginbilovandl.html
"Ginkgo biloba significantly increases the number of serotonin binding sites in the brain. As we age, the number of serotonin receptor sites on brain cells drops significantly. We become more susceptible to depression, impaired mental function, insomnia and sleep disturbances. Ginkgo may be taken along with St. John's wort or 5-HTP."
http://www.locateadoc.com/articles.cfm/search/103
**SJW**
http://www.biopsychiatry.com/hypericum.htm
It was that second quote that I found early on that got me worried. It specifies Ginkgo use with X right off, and doesn't reccomend it with X. Maybe its dose related?
Other research there suggests that its action in the brain is only in the aged population, BUT, isn't the X reaction in the brain similar to that of the aging process?
What I'd really like to know (and I'm sure the others out there using this product and 1s like it would like to know too), is Ginkgo's action while MDMA is fooling around with serotonin;
---->
What would be the result of increased serotonin binding sites produced by Ginkgo, while on MDMA?